Clinical Trial Update: Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial comparing hydroxychloroquine vs pioglitazone in combination therapy for type 2 diabetes with hyperglycemia; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Charles Drew University of Medicine and Science | Conditions: Diabetes Mellitus Type 2 With Hyperglycemia | Phase 2 | Status: TERMINATED | Results posted: 2022-10-20